Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  International Journal of Cancer

• Publication date

  1982-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910300621PMID 6186614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The antitumor effects of interferon

  1986cited by this paper
• Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain.

  1982cited by this paper
• Antigenic correlations between components of C243 and L cell interferons.

  1982cited by this paper
• Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X‐ray‐transformed C3H/10T1/2 cells under prolonged treatment with interferon

  1981cited by this paper
• Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice.

  1980cited by this paper
• High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor

  1980cited by this paper
• Antiviral mechanisms in the control of neoplasia

  1979cited by this paper
• Electrophoretically pure mouse interferon exerts multiple biologic effects.

  1979cited by this paper
• Human Fibroblast Interferon in the Control of Neoplasia

  1979cited by this paper
• On the varied biologic effects of interferon.

  1977cited by this paper
• Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes.

  1977cited by this paper
• Inhibitory effect of interferon on multiplication of Friend leukemia cells in vivo.

  1975cited by this paper
• A Method for the Large Scale Production of Potent Interferon Preparations

  1974cited by this paper
• Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells.

  1973cited by this paper
• Mechanism of the Antitumour Effect of Interferon in Mice

  1972cited by this paper
• Statistical Method in Biological Assay

  1953cited by this paper

• The added value of type I interferons to cytotoxic treatments of cancer.

  2017cites this paper
• Interferons and their stimulated genes in the tumor microenvironment.

  2014cites this paper
• Animal models and the tumor microenvironment: studies of tumor-host symbiosis.

  2014cites this paper
• From Concept to the Clinics: Development of Cancer Therapeutics

  2011cites this paper
• From Concept to the Clinics: Development of Novel Large Molecule Cancer Therapeutics

  2010cites this paper
• Distinct functions for type I and type II interferon in cancer immunoediting

  2010cites this paper
• Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs

  2010cites this paper
• IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2

  2008cites this paper
• Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

  2008cites this paper
• Interferon-alpha immunotherapy of melanoma: signal transduction, gene transcription, and the role of suppressor of cytokine signaling proteins in immune cells

  2007influential citation
• STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha

  2007cites this paper
• Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.

  2007cites this paper
• Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects.

  2007cites this paper
• The antitumor effects of interferon: a personal history.

  2007cites this paper
• Mice 5-Fluorouracil on Human Colon Cancers Implanted into Nude-Interferon and γ Mechanisms of Combined Effects of Updated Version

  2006cites this paper
• QCC SENSITIZED T LYMPHOCYTES RENDER DBA/2 BEIGE MICE

  2006cites this paper
• Inhibition by Mouse «//^-Interferonof the Multiplication of a/ß-Interferon-resistant Friend Erythroleukemia Cells Cocultured with Mouse Hepatocytes1

  2006cites this paper
• Interferons, immunity and cancer immunoediting

  2006cites this paper
• Direct and Indirect Effects of Interferon on in Vivo Murine Tumor Cell Growth 1

  2006cites this paper
• A critical function for type I interferons in cancer immunoediting

  2005cites this paper
• In vitro antiproliferative efficacy of Interferon-alpha,-gamma and Tumor Necrosis Factor on two human renal tumor xenografts

  2004cites this paper
• Comparative study of the antitumor effect of two types of murine recombinant interferons, (β) and (γ), against B16-F10 melanoma

  2004cites this paper
• Interferons, a group of multiple lymphokines

  2004cites this paper
• Antiangiogenic Therapy Against Experimental Glioblastoma Using Genetically Engineered Cells Producing Interferon-α, Angiostatin, or Endostatin

  2003cites this paper
• Interferon-alpha in tumor immunity and immunotherapy.

  2002cites this paper
• Endogenous type I interferons as a defense against tumors.

  2002cites this paper
• Pharmacological aspects of targeting cancer gene therapy to endothelial cells.

  2001cites this paper
• Murine B16 Melanoma Vaccination-Induced Tumor Immunity: Identification of Specific Immune Cells and Functions Involved

  2001cites this paper
• Interferon (IFN)- b Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN- a Differential Effects on Tumorigenicity and Host Response

  1999cites this paper
• Murine interferon-α1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-α/β therapy

  1999cites this paper
• Effectiveness of a Simply Designed Tumor Vaccine in Prevention of Malignant Melanoma Development

  1999cites this paper
• Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

  1999cites this paper
• Interferon (IFN)-β Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-α: Differential Effects on Tumorigenicity and Host Response

  1999cites this paper
• Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.

  1999cites this paper
• Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.

  1999cites this paper
• Nonviral Interferon α Gene Therapy Inhibits Growth of Established Tumors by Eliciting a Systemic Immune Response

  1998cites this paper
• Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.

  1998cites this paper
• Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity

  1997cites this paper
• Wherefore interferon?

  1997cites this paper
• Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.

  1996cites this paper
• Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.

  1996cites this paper
• The neglected role of type I interferon in the T-cell response: implications for its clinical use.

  1996cites this paper
• Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

  1995cites this paper
• Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes

  1995cites this paper
• Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes.

  1995cites this paper
• Role of interferons and other cytokines in the regulation of the immune response

  1995cites this paper
• Interferon-α Inhibits Erythropoietin-Induced Proliferation, but Not Differentiation, and Restricts Erythroleukemia Development

  1995cites this paper
• Suppressed proliferation of mouse hepatoma cells by conditioned media from interferon gamma-treated hepatocytes.

  1995cites this paper
• Local and Systemic Response of Mice to Interferon-α1 -Transfected Friend Leukemia Cells

  1995cites this paper
• Induction in interferon-alpha/beta-treated hepatocytes of the inhibitor of the multiplication of IFN-alpha/beta-resistant Friend leukemia cells.

  1994cites this paper
• Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in mice

  1994cites this paper
• Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.

  1994cites this paper
• IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.

  1994cites this paper
• Induction in Interferon-α/β-Treated Hepatocytes of the Inhibitor of the Multiplication of IFN-α/β-Resistant Friend Leukemia Cells

  1994cites this paper
• Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy.

  1994cites this paper
• Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice

  1994cites this paper
• Interferon alpha and 5'-deoxy-5-fluorouridine in colon cancer: effects as single agents and in combination on growth of xenograft tumours.

  1994cites this paper
• Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN α/β therapy of friend erythroleukemia visceral metastases

  1993cites this paper
• Activation of peritoneal macrophages in patients with gynecological malignancies by sizofiran and recombinant interferon-γ

  1993cites this paper
• The Inhibitory Effects of Growth Factors and Cytokines on Cell Proliferation

  1993cites this paper
• Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.

  1993cites this paper
• Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.

  1993cites this paper
• Molecular Oncology and Clinical Applications

  1993cites this paper
• MRS Studies on Experimental Tumours Treated with TNF

  1993cites this paper
• Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.

  1993cites this paper
• Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.

  1992cites this paper
• Mechanisms of Combined IL-1/IL-2 and IL-1/IFN Therapy in Mice Injected with Metastatic Tumor Cells

  1992cites this paper
• Spin-lattice relaxation in murine tumors after in vivo treatment with interferon alpha/beta or tumor necrosis factor alpha.

  1992cites this paper
• Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy.

  1992cites this paper
• Spin‐lattice relaxation in murine tumors after in vivo treatment with interferon α/β or tumor necrosis factor α

  1992cites this paper
• The potential role of cytokines in cancer therapy.

  1992cites this paper
• In vivo treatment with interferon causes augmentation of IL‐2 induced lymphokine‐activated killer cells in the organs of mice

  1991cites this paper
• Influence of the site of tumor growth on the capacity of a low tumorigenic line of Friend erythroleukemia cells to differentiate.

  1991cites this paper
• Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases

  1991cites this paper
• Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice

  1991cites this paper
• Antitumour effects of interferons: past, present and future

  1991cites this paper
• Synergistic anti‐tumor effects of combined IL‐1/IFN‐α/β therapy in mice injected with met astatic friend erythroleukemia cells

  1991cites this paper
• An Interferon-Induced 16-kD Protein Is Present in the Membranes of Interferon-Sensitive but Not in Interferon-Resistant Mouse Cells

  1991cites this paper
• Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.

  1991cites this paper
• Experimental Rationale for Continuous Infusion Chemotherapy

  1991cites this paper
• Inhibition by Mouse α/β-Interferon of the Multiplication of α/β-Interferon-resistant Friend Erythroleukemia Cells Cocultured with Mouse Hepatocytes

  1990cites this paper
• Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.

  1990cites this paper
• Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon.

  1990cites this paper
• Antitumor Activity of T Cells in Lymphoid Organs Induced by Interferon in Tumor-Bearing Mice

  1990cites this paper
• Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.

  1990cites this paper
• Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases

  1990cites this paper
• Importance of interferon α in the resistance of allogeneic C57B1/6 mice to the multiplication of friend erythroleukemia cells in the liver

  1990cites this paper
• Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

  1989cites this paper
• Natural resistance in mice against Friend cells injected intravenously. III. Comparison between in vivo and in vitro passaged interferon-sensitive (745) and interferon-resistant (3Cl8) cell clones.

  1989cites this paper
• Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.

  1989cites this paper
• Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.

  1989cites this paper
• Natural resistance in mice against Friend leukemia cells. II. Studies with in vivo passaged interferon-sensitive and interferon-resistant cell clones.

  1989cites this paper
• Animal models in interferon research: Some current trends

  1989cites this paper
• Interferons: biological and clinical effects.

  1989cites this paper
• Anti‐tumor effects of interleukin‐2 and interleukin‐1 in mice transplanted with different syngeneic tumors

  1989cites this paper
• Antitumor effects of interferon.

  1989cites this paper
• Interferon-gamma: a review.

  1989cites this paper
• The Effect of Interferon on Experimental Tumor Metastases

  1989cites this paper
• Interleukin‐1β induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti‐tumor effects of tumor necrosis factor α or β

  1989cites this paper
• Tumour Necrosis Factor and Interleukin-6: Structure and Mechanism of Action of the Molecular, Cellular and in Vivo Level

  1989cites this paper